126 related articles for article (PubMed ID: 28811560)
21. Herpes virus microRNA expression and significance in serous ovarian cancer.
Pandya D; Mariani M; McHugh M; Andreoli M; Sieber S; He S; Dowell-Martino C; Fiedler P; Scambia G; Ferlini C
PLoS One; 2014; 9(12):e114750. PubMed ID: 25485872
[TBL] [Abstract][Full Text] [Related]
22. Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.
Bai Y; Ding L; Baker S; Bai JM; Rath E; Jiang F; Wu J; Jiang H; Stuart G
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):336. PubMed ID: 27766936
[TBL] [Abstract][Full Text] [Related]
23. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
Ruan L; Xie Y; Liu F; Chen X
Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
[TBL] [Abstract][Full Text] [Related]
24. Selection of suitable reference genes for gene expression studies in normal human ovarian tissues, borderline ovarian tumours and ovarian cancer.
Ofinran O; Bose U; Hay D; Abdul S; Tufatelli C; Khan R
Mol Med Rep; 2016 Dec; 14(6):5725-5731. PubMed ID: 27840988
[TBL] [Abstract][Full Text] [Related]
25. Two microRNA signatures for malignancy and immune infiltration predict overall survival in advanced epithelial ovarian cancer.
Korsunsky I; Parameswaran J; Shapira I; Lovecchio J; Menzin A; Whyte J; Dos Santos L; Liang S; Bhuiya T; Keogh M; Khalili H; Pond C; Liew A; Shih A; Gregersen PK; Lee AT
J Investig Med; 2017 Oct; 65(7):1068-1076. PubMed ID: 28716985
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice.
Fornari TA; Donate PB; Assis AF; Macedo C; Sakamoto-Hojo ET; Donadi EA; Passos GA
PLoS One; 2015; 10(11):e0142688. PubMed ID: 26606254
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
[TBL] [Abstract][Full Text] [Related]
28. GnRH-II mRNA expression in tumor tissue and peripheral blood mononuclear cells (PBMCs) in patients with malignant and benign ovarian tumors.
Serin IS; Tanriverdi F; Ata CD; Akalin H; Ozcelik B; Ozkul Y; Kelestimur F
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):92-6. PubMed ID: 20018426
[TBL] [Abstract][Full Text] [Related]
29. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
30. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.
van Jaarsveld MT; Helleman J; Boersma AW; van Kuijk PF; van Ijcken WF; Despierre E; Vergote I; Mathijssen RH; Berns EM; Verweij J; Pothof J; Wiemer EA
Oncogene; 2013 Sep; 32(36):4284-93. PubMed ID: 23045278
[TBL] [Abstract][Full Text] [Related]
31. Identification of IGF-1-enhanced cytokine expressions targeted by miR-181d in glioblastomas via an integrative miRNA/mRNA regulatory network analysis.
Ho KH; Chen PH; Hsi E; Shih CM; Chang WC; Cheng CH; Lin CW; Chen KC
Sci Rep; 2017 Apr; 7(1):732. PubMed ID: 28389653
[TBL] [Abstract][Full Text] [Related]
32. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
[TBL] [Abstract][Full Text] [Related]
33. Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer.
Zou J; Yin F; Wang Q; Zhang W; Li L
Int J Clin Exp Pathol; 2015; 8(6):6847-58. PubMed ID: 26261572
[TBL] [Abstract][Full Text] [Related]
34. Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality.
Hossain MA; Saiful Islam SM; Quinn JMW; Huq F; Moni MA
J Biomed Inform; 2019 Dec; 100():103313. PubMed ID: 31655274
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
Bagnoli M; Canevari S; Califano D; Losito S; Maio MD; Raspagliesi F; Carcangiu ML; Toffoli G; Cecchin E; Sorio R; Canzonieri V; Russo D; Scognamiglio G; Chiappetta G; Baldassarre G; Lorusso D; Scambia G; Zannoni GF; Savarese A; Carosi M; Scollo P; Breda E; Murgia V; Perrone F; Pignata S; De Cecco L; Mezzanzanica D;
Lancet Oncol; 2016 Aug; 17(8):1137-1146. PubMed ID: 27402147
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of transient receptor potential cation channel, subfamily C, member 1 contributes to drug resistance and high histological grade in ovarian cancer.
Liu X; Zou J; Su J; Lu Y; Zhang J; Li L; Yin F
Int J Oncol; 2016 Jan; 48(1):243-52. PubMed ID: 26647723
[TBL] [Abstract][Full Text] [Related]
38. Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer.
Ray M; Ruffalo MM; Bar-Joseph Z
Genes Chromosomes Cancer; 2019 Jan; 58(1):34-42. PubMed ID: 30285311
[TBL] [Abstract][Full Text] [Related]
39. Identification and comparative profiling of ovarian and testicular microRNAs in the swimming crab Portunus trituberculatus.
Meng X; Zhang X; Li J; Liu P
Gene; 2018 Jan; 640():6-13. PubMed ID: 29031772
[TBL] [Abstract][Full Text] [Related]
40. Differential MicroRNA Expression Profiles in Primary and Recurrent Epithelial Ovarian Cancer.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Lee YS; Cho YL
Anticancer Res; 2015 May; 35(5):2611-7. PubMed ID: 25964536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]